Vext Science Inc

Company Profile

Vext Science Inc had its IPO on under the ticker symbol VEXTF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Vext Science Inc has a staff strength of 0 employees.

Stock update

Shares of Vext Science Inc opened at $0.19 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.18 - $0.2, and closed at $0.2.

This is a +11.73% increase from the previous day's closing price.

A total volume of 52,776 shares were traded at the close of the day’s session.

In the last one week, shares of Vext Science Inc have increased by +9.11%.

Vext Science Inc's Key Ratios

Vext Science Inc has a market cap of $16.50 million, indicating a price to book ratio of 0.176 and a price to sales ratio of 0.3138.

In the last 12-months Vext Science Inc’s revenue was $34.15 million with a gross profit of $18.42 million and an EBITDA of $10.56 million. The EBITDA ratio measures Vext Science Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vext Science Inc’s operating margin was 11.06% while its return on assets stood at 2.18% with a return of equity of 10.72%.

In Q2, Vext Science Inc’s quarterly earnings growth was a negative -64.3% while revenue growth was a positive 4.8%.

Vext Science Inc’s PE and PEG Ratio

Forward PE

5.2247

Trailing PE

3.3317

PEG

Its diluted EPS in the last 12-months stands at $0.06 per share while it has a forward price to earnings multiple of 5.2247 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vext Science Inc’s profitability.

Vext Science Inc stock is trading at a EV to sales ratio of 0.7781 and a EV to EBITDA ratio of 1.7493. Its price to sales ratio in the trailing 12-months stood at 0.3138.

Vext Science Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$121.37 million

Total Liabilities

$10.45 million

Operating Cash Flow

$0

Capital Expenditure

$359040

Dividend Payout Ratio

0%

Vext Science Inc ended 2024 with $121.37 million in total assets and $0 in total liabilities. Its intangible assets were valued at $121.37 million while shareholder equity stood at $72.73 million.

Vext Science Inc ended 2024 with $0 in deferred long-term liabilities, $10.45 million in other current liabilities, in common stock, $33.93 million in retained earnings and $2.07 million in goodwill. Its cash balance stood at $4.28 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $33.23 million.

Vext Science Inc’s total current assets stands at $38.57 million while long-term investments were $1.74 million and short-term investments were $0. Its net receivables were $3.63 million compared to accounts payable of $1.70 million and inventory worth $13.62 million.

In 2024, Vext Science Inc's operating cash flow was $0 while its capital expenditure stood at $359040.

Comparatively, Vext Science Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.2

52-Week High

$0.2676

52-Week Low

$0.1447

Analyst Target Price

$

Vext Science Inc stock is currently trading at $0.2 per share. It touched a 52-week high of $0.2676 and a 52-week low of $0.2676. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.19 and 200-day moving average was $0.19 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 1890.6% of the company’s stock are held by insiders while 863.7% are held by institutions.